Strategies for managing crossborder reporting obligations.
Reputational risk
US banking regulators have altered some aspects of their supervisory stances, eliminating reputational risk as a standalone basis for supervisory criticism, among other moves.
Principal third-party disclosure mechanisms and the common pitfalls for pharmaceutical compliance and risk teams.
Supervision, enforcement, and the need to embrace outcomes-focused conduct.
The order, mandates a crackdown on "debanking" and ends the use of reputational risk in regulatory oversight.
GRIP's US Content Manager Julie DiMauro speaks with Karen Brown, Head of KYC compliance at a New York correspondent bank.
Maybe reputation has loomed too large in risk assessment but, says Julie DiMauro, it would be unwise to disregard it entirely.
Criminal convictions for a former McKinsey partner and ex-Volkswagen directors for compliance failings and misconduct.